Ceftolozane–tazobactam versus meropenem for treatment of nosocomial pneumonia (ASPECT-NP): a randomised, controlled, double-blind, phase 3, non-inferiority trial
| Autor: | Kollef, Marin H, Nováček, Martin, Kivistik, Ülo, Réa-Neto, Álvaro, Shime, Nobuaki, Martin-Loeches, Ignacio, Timsit, Jean-François, Wunderink, Richard G, Bruno, Christopher J, Huntington, Jennifer A, Lin, Gina, Yu, Brian, Butterton, Joan R, Rhee, Elizabeth G * |
|---|---|
| Zdroj: | In The Lancet Infectious Diseases December 2019 19(12):1299-1311 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|